A carregar...

Systemic therapy for metastatic pancreatic adenocarcinoma

Systemic treatment of metastatic pancreatic adenocarcinoma achieves only modest benefits, with evidence indicating a survival advantage with 5-fluorouracil (5-FU) over best supportive care alone, and further advantage of single-agent gemcitabine over 5-FU. There are very few regimens better than sin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lawrence, Ben, Findlay, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3126009/
https://ncbi.nlm.nih.gov/pubmed/21789129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834009357188
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!